RIBBON-1: randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal growth factor receptor 2-negative, locally recurrent or metastatic breast cancer
| Image |  |
|---|---|
| Description | scientific article published on 7 March 2011 |
| Author/s |
author: Denise A Yardley Joyce O'Shaughnessy Edith A. Perez Igor N. Bondarenko |
| Publication date | March 7, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |